Insulet share price today
(NASDAQ: PODD)

Name: Insulet Share Price Today (NASDAQ: PODD) - Insulet Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Insulet share price is $277.2 & ₹23,975.03 as on 24 Jan 2025, 2.30 'hrs' IST

$277.2

▲

-1.69

(-0.61%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Insulet share price in Dollar and Rupees. Guide to invest in Insulet stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Insulet, along with analyst recommendations, forecasts, and comprehensive financials.

Insulet share price movements

Today's Low: $272.73
Today's High: $279.71
$277.20
1.61%
Downside
Day's Volatility :2.5%
Upside
0.9%
52 Weeks Low: $160.19
52 Weeks High: $282.86
$277.20
42.21%
Downside
52 Weeks Volatility :43.37%
Upside
2.0%

Insulet Returns

Period	Insulet Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	19.37%	-5.5%	0.0%
6 Months	44.28%	-4.3%	0.0%
1 Year	40.38%	1.6%	0.0%
3 Years	31.66%	9.8%	-11.0%

Insulet Key Statistics

in dollars & INR

Previous Close	$278.89
Open	$279.23
Today's High	$279.7141
Today's Low	$272.73
Market Capitalization	$19.6B
Today's Volume	$537.9K
52 Week High	$282.86
52 Week Low	$160.19
Revenue TTM	$2.0B
EBITDA	$410.6M
Earnings Per Share (EPS)	$5.86
PE Ratio	47.59
Profit Margin	21.22%
Quarterly Earnings Growth YOY	0.46%
Return On Equity TTM	48.79%

How to invest in Insulet Stock (PODD) from India?

It is very easy for Indian residents to invest directly in Insulet from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Insulet stock in both Indian Rupees (INR) and US Dollars (USD). Search for Insulet or PODD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Insulet or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Insulet shares which would translate to 0.003 fractional shares of Insulet as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Insulet, in just a few clicks!

Returns in Insulet for Indian investors in Rupees

Investment Value

₹1,00,000

Insulet investment value today

Current value as on today

₹1,43,582

Returns

₹43,582

(+43.58%)

Returns from Insulet Stock

₹39,528 (+39.53%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Insulet

79%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Insulet on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 79% more investors are searching Insulet in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Insulet

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	605	1.66	0.04%

Global Institutional Holdings in Insulet

Vanguard Group Inc
12.08%
FMR Inc
11.36%
Capital Research Global Investors
11.08%
BlackRock Inc
8.53%
State Street Corp
4.16%
Baillie Gifford & Co Limited.
3.24%

Analyst Recommendation on Insulet

Buy

82%Buy

17%Hold

0%Sell

Based on 28 Wall street analysts offering stock ratings for Insulet(by analysts ranked 0 to 5 stars)

Based on 28 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Insulet

What analysts predicted

Upside of 5.44%

Target:

$292.29

Current:

$277.20

Insights on Insulet

Price Movement
In the last 3 months, PODD stock has moved up by 18.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 488.5M → 372.6M (in $), with an average decrease of 23.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 188.6M → 77.5M (in $), with an average decrease of 58.9% per quarter
PODD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 65.5% return, outperforming this stock by 29.0%
PODD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 109.0%
Price to Sales
ForPODD every $1 of sales, investors are willing to pay $9.8, whereas for Boston Scientific Corp., the investors are paying $9.3 for every $1 of sales.

Insulet Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$563.8M	↑ 21.57%
Net Income	$3.3M	↓ 112.27%
Net Profit Margin	0.58%	↑ 6.37%

	FY19	Y/Y Change
Revenue	$738.2M	↑ 30.93%
Net Income	$11.6M	↑ 252.37%
Net Profit Margin	1.57%	↑ 0.99%

	FY20	Y/Y Change
Revenue	$904.4M	↑ 22.51%
Net Income	$6.8M	↓ 41.38%
Net Profit Margin	0.75%	↓ 0.82%

	FY21	Y/Y Change
Revenue	$1.1B	↑ 21.49%
Net Income	$16.8M	↑ 147.06%
Net Profit Margin	1.53%	↑ 0.78%

	FY22	Y/Y Change
Revenue	$1.3B	↑ 18.79%
Net Income	$4.6M	↓ 72.62%
Net Profit Margin	0.35%	↓ 1.18%

	FY23	Y/Y Change
Revenue	$1.7B	↑ 30.02%
Net Income	$206.3M	↑ 4384.78%
Net Profit Margin	12.16%	↑ 11.81%

	Q2 FY23	Q/Q Change
Revenue	$396.5M	↑ 10.72%
Net Income	$27.3M	↑ 14.71%
Net Profit Margin	6.89%	↑ 0.24%

	Q3 FY23	Q/Q Change
Revenue	$432.7M	↑ 9.13%
Net Income	$51.9M	↑ 90.11%
Net Profit Margin	11.99%	↑ 5.1%

	Q4 FY23	Q/Q Change
Revenue	$509.8M	↑ 17.82%
Net Income	$103.3M	↑ 99.04%
Net Profit Margin	20.26%	↑ 8.27%

	Q1 FY24	Q/Q Change
Revenue	$441.7M	↓ 13.36%
Net Income	$51.5M	↓ 50.15%
Net Profit Margin	11.66%	↓ 8.6%

	Q2 FY24	Q/Q Change
Revenue	$488.5M	↑ 10.6%
Net Income	$188.6M	↑ 266.21%
Net Profit Margin	38.61%	↑ 26.95%

	Q3 FY24	Q/Q Change
Revenue	$372.6M	↓ 23.73%
Net Income	$77.5M	↓ 58.91%
Net Profit Margin	20.8%	↓ 17.81%

	FY18	Y/Y Change
Profit	$370.2M	↑ 33.55%

	FY19	Y/Y Change
Profit	$480.3M	↑ 29.75%

	FY20	Y/Y Change
Profit	$582.3M	↑ 21.24%

	FY21	Y/Y Change
Profit	$752.1M	↑ 29.16%

	FY22	Y/Y Change
Profit	$805.6M	↑ 7.11%

	FY23	Y/Y Change
Profit	$1.2B	↑ 43.98%

	Q2 FY23	Q/Q Change
Profit	$264.9M	↑ 10.15%

	Q3 FY23	Q/Q Change
Profit	$293.3M	↑ 10.72%

	Q4 FY23	Q/Q Change
Profit	$361.2M	↑ 23.15%

	Q1 FY24	Q/Q Change
Profit	$309.9M	↓ 14.2%

	Q2 FY24	Q/Q Change
Profit	$334.2M	↑ 7.84%

	Q3 FY24	Q/Q Change
Profit	$377.1M	↑ 12.84%

	FY18	Y/Y Change
Operating Cash Flow	$35.9M	↓ 12.88%
Investing Cash Flow	$-184.5M	↓ 12.47%
Financing Cash Flow	$-8.7M	↓ 102.85%

	FY19	Y/Y Change
Operating Cash Flow	$98.4M	↑ 174.1%
Investing Cash Flow	$-73.6M	↓ 60.11%
Financing Cash Flow	$73.5M	↓ 948.24%

	FY20	Y/Y Change
Operating Cash Flow	$84.0M	↓ 14.63%
Investing Cash Flow	$14.0M	↓ 119.02%
Financing Cash Flow	$605.5M	↑ 723.81%

	FY21	Y/Y Change
Operating Cash Flow	$-68.1M	↓ 181.07%
Investing Cash Flow	$-82.7M	↓ 690.71%
Financing Cash Flow	$40.7M	↓ 93.28%

	FY22	Y/Y Change
Operating Cash Flow	$119.0M	↓ 274.74%
Investing Cash Flow	$-191.1M	↑ 131.08%
Financing Cash Flow	$-40.3M	↓ 199.02%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$44.0M	↑ 8700.0%
Investing Cash Flow	$-23.1M	↓ 45.13%
Financing Cash Flow	$3.2M	↓ 126.45%

Insulet Technicals Summary

Sell

Neutral

Buy

Insulet is currently in a neutral trading position according to technical analysis indicators.

Insulet Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Insulet Corporation	4.97%	44.28%	40.38%	31.66%	44.5%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Insulet Corporation	47.59	47.59	4.18	3.21	0.49	0.08	NA	15.94
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Insulet Corporation	Buy	$19.6B	44.5%	47.59	21.22%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Organization	Insulet
Employees	3000
CEO	Dr. James R. Hollingshead Ph.D.
Industry	Health Technology

Management People of Insulet

Name	Title
Dr. James R. Hollingshead Ph.D.	President, CEO & Director
Ms. Lauren Budden	Group VP, Chief Accounting Officer & Controller
Mr. Mark Field	Senior VP & CTO
Mr. John Wodick Kapples J.D.	Senior VP & General Counsel
Mr. Eric Benjamin	Executive VP, Chief Product & Customer Experience Officer
Ms. Ana Maria Chadwick	Executive VP, CFO & Treasurer
Mr. Prem Singh	Senior Vice President of Global Operations
June Lazaroff	Senior Director of Investor Relations
Ms. Laetitia Cousin	Senior VP of Regulatory Affairs, Quality Assurance & Compliance
Angela Geryak Wiczek	Senior Director of Corporate Communications

Important FAQs about investing in Insulet (PODD) from India :

What is Insulet share price today?

Insulet share price today stands at $277.20, Open: $279.23 ; Previous Close: $278.89 ; High: $279.71 ; Low: $272.73 ; 52 Week High: $282.86 ; 52 Week Low: $160.19. The stock opens at $279.23, after a previous close of $278.89. The stock reached a daily high of $279.71 and a low of $272.73, with a 52-week high of $282.86 and a 52-week low of $160.19.

Can Indians buy Insulet shares?

Yes, Indians can invest in the Insulet (PODD) from India.

With INDmoney, you can buy Insulet at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Insulet at zero transaction cost.

How can I buy Insulet shares from India?

It is very easy to buy Insulet from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Insulet be purchased?

Yes, you can buy fractional shares of Insulet with INDmoney app.

What are the documents required to start investing in Insulet stocks?

To start investing in Insulet, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.